Physician profile
Ernesto Rivera
NPI 1639146533
$35,798.21
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25K · 2020: $5,319 · 2021: $48.67 · 2022: $3,367 · 2023: $1,640.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $824 · Food and Beverage: $816.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $823.66 |
| Food and Beverage | $816.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $14,022.35 | 2019-2020 | |
| Medtronic Vascular, INC. | $10,012.38 | 2019-2020 | |
| Abiomed | $2,732.23 | 2019 | |
| Penumbra, INC. | $2,659.37 | 2019-2023 | Indigo System |
| Abbott Laboratories | $2,159.82 | 2019-2022 | |
| Boston Scientific Corporation | $1,222.11 | 2019-2022 | |
| Terumo Medical Corporation | $730.13 | 2019-2022 | |
| Cardinal Health 200 LLC | $393.20 | 2019-2020 | |
| Philips North America LLC | $363.52 | 2019-2020 | |
| Amgen INC. | $339.16 | 2019-2020 | |
| Medtronic, INC. | $241.15 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $226.35 | 2019-2020 | |
| Acist Medical Systems, INC. | $131.57 | 2020 | |
| Pfizer INC. | $113.10 | 2020 | |
| Allergan, INC. | $95.05 | 2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $75.61 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $67.41 | 2019-2020 | |
| Cardiovascular Systems INC. | $62.03 | 2019-2020 | |
| Amarin Pharma, INC. | $51.62 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $46.11 | 2019-2020 | |
| Arbor Pharmaceuticals, INC. | $33.78 | 2020 | |
| Ucb, INC. | $20.16 | 2023 | Cimzia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ernesto Rivera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.